Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Reducing inappropriate antibiotic prescribing for children in primary care: a cluster randomised controlled trial of two interventions.

Lemiengre MB, Verbakel JY, Colman R, De Burghgraeve T, Buntinx F, Aertgeerts B, De Baets F, De Sutter A.

Br J Gen Pract. 2018 Mar;68(668):e204-e210. doi: 10.3399/bjgp18X695033. Epub 2018 Feb 12.

PMID:
29440016
2.

Occurrence of Malnutrition and Associated Factors in Community-Dwelling Older Adults: Those with a Recent Diagnosis of Cancer Are at Higher Risk.

Van Den Broeke C, De Burghgraeve T, Ummels M, Gescher N, Deckx L, Tjan-Heijnen V, Buntinx F, van den Akker M.

J Nutr Health Aging. 2018;22(2):191-198. doi: 10.1007/s12603-017-0882-7.

PMID:
29380845
3.

Design, synthesis and evaluation against Chikungunya virus of novel small-molecule antiviral agents.

Tardugno R, Giancotti G, De Burghgraeve T, Delang L, Neyts J, Leyssen P, Brancale A, Bassetto M.

Bioorg Med Chem. 2018 Feb 15;26(4):869-874. doi: 10.1016/j.bmc.2018.01.002. Epub 2018 Jan 6.

PMID:
29336951
4.

Point-of-care C reactive protein to identify serious infection in acutely ill children presenting to hospital: prospective cohort study.

Verbakel JY, Lemiengre MB, De Burghgraeve T, De Sutter A, Aertgeerts B, Bullens DMA, Shinkins B, Van den Bruel A, Buntinx F.

Arch Dis Child. 2017 Dec 21. pii: archdischild-2016-312384. doi: 10.1136/archdischild-2016-312384. [Epub ahead of print]

PMID:
29269559
5.

The influence of coping strategies on subsequent well-being in older patients with cancer: A comparison with 2 control groups.

Baitar A, Buntinx F, De Burghgraeve T, Deckx L, Schrijvers D, Wildiers H, van den Akker M.

Psychooncology. 2017 Nov 21. doi: 10.1002/pon.4587. [Epub ahead of print]

PMID:
29161462
6.

The utilization of formal and informal home care by older patients with cancer: a Belgian cohort study with two control groups.

Baitar A, Buntinx F, De Burghgraeve T, Deckx L, Bulens P, Wildiers H, van den Akker M.

BMC Health Serv Res. 2017 Sep 12;17(1):644. doi: 10.1186/s12913-017-2594-4.

7.

Erratum to: Should all acutely ill children in primary care be tested with point-of-care CRP: a cluster randomised trial.

Verbakel JY, Lemiengre MB, De Burghgraeve T, De Sutter A, Aertgeerts B, Shinkins B, Perera R, Mant D, Van den Bruel A, Buntinx F.

BMC Med. 2017 May 2;15(1):93. doi: 10.1186/s12916-017-0861-1. No abstract available.

8.

Should all acutely ill children in primary care be tested with point-of-care CRP: a cluster randomised trial.

Verbakel JY, Lemiengre MB, De Burghgraeve T, De Sutter A, Aertgeerts B, Shinkins B, Perera R, Mant D, Van den Bruel A, Buntinx F.

BMC Med. 2016 Oct 6;14(1):131. doi: 10.1186/s12916-016-0679-2. Erratum in: BMC Med. 2017 May 2;15(1):93.

9.

The viral capping enzyme nsP1: a novel target for the inhibition of chikungunya virus infection.

Delang L, Li C, Tas A, Quérat G, Albulescu IC, De Burghgraeve T, Guerrero NA, Gigante A, Piorkowski G, Decroly E, Jochmans D, Canard B, Snijder EJ, Pérez-Pérez MJ, van Hemert MJ, Coutard B, Leyssen P, Neyts J.

Sci Rep. 2016 Aug 22;6:31819. doi: 10.1038/srep31819.

10.

Validating a decision tree for serious infection: diagnostic accuracy in acutely ill children in ambulatory care.

Verbakel JY, Lemiengre MB, De Burghgraeve T, De Sutter A, Aertgeerts B, Bullens DM, Shinkins B, Van den Bruel A, Buntinx F.

BMJ Open. 2015 Aug 7;5(8):e008657. doi: 10.1136/bmjopen-2015-008657.

11.

Design, synthesis, optimization and antiviral activity of a class of hybrid dengue virus E protein inhibitors.

Jadav SS, Kaptein S, Timiri A, De Burghgraeve T, Badavath VN, Ganesan R, Sinha BN, Neyts J, Leyssen P, Jayaprakash V.

Bioorg Med Chem Lett. 2015 Apr 15;25(8):1747-1752. doi: 10.1016/j.bmcl.2015.02.059. Epub 2015 Mar 2.

PMID:
25791449
12.
13.

Diagnosing serious infections in acutely ill children in ambulatory care (ERNIE 2 study protocol, part A): diagnostic accuracy of a clinical decision tree and added value of a point-of-care C-reactive protein test and oxygen saturation.

Verbakel JY, Lemiengre MB, De Burghgraeve T, De Sutter A, Bullens DM, Aertgeerts B, Buntinx F; ERNIE 2 collaboration.

BMC Pediatr. 2014 Oct 2;14:207. doi: 10.1186/1471-2431-14-207.

14.

In search of flavivirus inhibitors: evaluation of different tritylated nucleoside analogues.

Chatelain G, Debing Y, De Burghgraeve T, Zmurko J, Saudi M, Rozenski J, Neyts J, Van Aerschot A.

Eur J Med Chem. 2013 Jul;65:249-55. doi: 10.1016/j.ejmech.2013.04.034. Epub 2013 Apr 24.

PMID:
23721953
15.

3',5'Di-O-trityluridine inhibits in vitro flavivirus replication.

De Burghgraeve T, Selisko B, Kaptein S, Chatelain G, Leyssen P, Debing Y, Jacobs M, Van Aerschot A, Canard B, Neyts J.

Antiviral Res. 2013 May;98(2):242-7. doi: 10.1016/j.antiviral.2013.01.011. Epub 2013 Mar 5.

PMID:
23470860
16.

Computer-aided identification, design and synthesis of a novel series of compounds with selective antiviral activity against chikungunya virus.

Bassetto M, De Burghgraeve T, Delang L, Massarotti A, Coluccia A, Zonta N, Gatti V, Colombano G, Sorba G, Silvestri R, Tron GC, Neyts J, Leyssen P, Brancale A.

Antiviral Res. 2013 Apr;98(1):12-8. doi: 10.1016/j.antiviral.2013.01.002. Epub 2013 Feb 1.

PMID:
23380636
17.

An analogue of the antibiotic teicoplanin prevents flavivirus entry in vitro.

De Burghgraeve T, Kaptein SJ, Ayala-Nunez NV, Mondotte JA, Pastorino B, Printsevskaya SS, de Lamballerie X, Jacobs M, Preobrazhenskaya M, Gamarnik AV, Smit JM, Neyts J.

PLoS One. 2012;7(5):e37244. doi: 10.1371/journal.pone.0037244. Epub 2012 May 18.

18.

Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug.

Mastrangelo E, Pezzullo M, De Burghgraeve T, Kaptein S, Pastorino B, Dallmeier K, de Lamballerie X, Neyts J, Hanson AM, Frick DN, Bolognesi M, Milani M.

J Antimicrob Chemother. 2012 Aug;67(8):1884-94. doi: 10.1093/jac/dks147. Epub 2012 Apr 25.

19.

Broad antiviral activity of carbohydrate-binding agents against the four serotypes of dengue virus in monocyte-derived dendritic cells.

Alen MM, De Burghgraeve T, Kaptein SJ, Balzarini J, Neyts J, Schols D.

PLoS One. 2011;6(6):e21658. doi: 10.1371/journal.pone.0021658. Epub 2011 Jun 30.

20.

A derivate of the antibiotic doxorubicin is a selective inhibitor of dengue and yellow fever virus replication in vitro.

Kaptein SJ, De Burghgraeve T, Froeyen M, Pastorino B, Alen MM, Mondotte JA, Herdewijn P, Jacobs M, de Lamballerie X, Schols D, Gamarnik AV, Sztaricskai F, Neyts J.

Antimicrob Agents Chemother. 2010 Dec;54(12):5269-80. doi: 10.1128/AAC.00686-10. Epub 2010 Sep 13.

21.

Substituted imidazopyridines as potent inhibitors of HCV replication.

Vliegen I, Paeshuyse J, De Burghgraeve T, Lehman LS, Paulson M, Shih IH, Mabery E, Boddeker N, De Clercq E, Reiser H, Oare D, Lee WA, Zhong W, Bondy S, Pürstinger G, Neyts J.

J Hepatol. 2009 May;50(5):999-1009. doi: 10.1016/j.jhep.2008.12.028. Epub 2009 Feb 26.

PMID:
19303654
22.

Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection.

Alen MM, Kaptein SJ, De Burghgraeve T, Balzarini J, Neyts J, Schols D.

Virology. 2009 Apr 25;387(1):67-75. doi: 10.1016/j.virol.2009.01.043. Epub 2009 Mar 4.

Supplemental Content

Loading ...
Support Center